FDA-Approved Peanut Allergy Immunotherapy Palforzia Exits Market

Source Summary

Palforzia, the first and only FDA-approved oral immunotherapy product for peanut allergy treatment, has exited the market. The standardized peanut protein product had been approved by the FDA.